Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Like this? Share it with your network

Share

Chta morris-terry-canterpene-presentation-copy3

on

  • 560 views

Re-branding hemp as Canterpene to

Re-branding hemp as Canterpene to

Statistics

Views

Total Views
560
Views on SlideShare
560
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Medicine can use the 12 step HACCP methodology to effectively deliver an integrated service Here I am with my partner Silas Kanning and Medical Director Terry Grossman who is a practitioner of leading edge integrated medicine
  • HACCP is not a quality or efficiency system but fully integrates with the Define/Measure/Analyze/Improve/Control cycles Open source access to knowledge Facilitates QA/QC and Lean
  • You assemble and direct your personal healthspan provider team  
  • What you plan to do with your life will determine the aggressiveness with which to apply your plan
  • From Our Family to yours “ Live long and Prosper”.

Chta morris-terry-canterpene-presentation-copy3 Presentation Transcript

  • 1. REBRANDING HEMP FOR THE NEUTRACEUTICAL MARKET CANTERPENE AS A HEALTHSPAN EXTENSION SUPPLEMENT
  • 2.
    • Lifespan Pharma Inc.
    • Morris Johnson, CTO, Founder
    • Terry Grossman, M.D., Medical Director
    • Silas Kanning,
    • Co-founder
  • 3. REBRANDING HEMP AS CANTERPENE MAKES SENSE FOR THE NATURAL HEALTH PRODUCT/ DSHEA FOOD SUPPLEMENT MARKETS
  • 4. 35 YEARS AGO RAPESEED EXPERIENCED THE SAME PROBLEMS AFFECTING HEMP TODAY
    • Growers needed to rebrand something that was associated with a machine oil regarded as too toxic for humans to consume
    • Low Erucic Acid Rapeseed (LEAR)?
    • “ CANadian source of OLeic Acid” became CANOLA
    • It was promoted as a safe, nutritious, multi-purpose human and animal food ingredient
  • 5. Hemp is undergoing a similar identity crisis i n the minds of many today
  • 6.
    • When you Google “hemp” you get a large number of “POT” hits
    • Purveyors of recreational and medicinal marijuana use “hemp” indiscriminately when speaking about marijuana
  • 7. SOME CANADIAN HEMP PRODUCTS ASSOCIATE HEMP WITH MARIJUANA
  • 8. ASSOCIATING HEMP WITH MARIJUANA IS CREATING CONSUMER CONFUSION
    • Solutions:
    • Litigate?
    • Regulate?
    • Educate?
    • Ignore?
  • 9. AFTER MUCH CONSIDERATION WE CONCLUDED NONE OF THE ABOVE SOLUTIONS ARE PRACTICAL OR COST EFFECTIVE
    • Some hemp manufacturers want to capitalize on the science which has popularized the term “Medical Marijuana”
    • The best solution: REBRANDING
  • 10. REBRAND CANADIAN HEMP AS CANTERPENE
    • We link Canadian Hemp with the message
    • “ Extend Health-span and Life-span naturally with cannabis chemistry
  • 11. WE HAVE PATENTED CANTERPENE AS A PROPRIETARY FORMULATION OF MILLED HEMPSEED
  • 12. AGING CAN BE BRUTAL
  • 13. IT IS POSSIBLE TO GROW OLDER WITHOUT AGING AT ANY AGE 60 yrs old 80 yrs old
  • 14. ANTIAGING IS AN ENORMOUS MARKET
    • 76 million baby boomers in the US
    • 6 million “boomies” in Canada
    • Boomers now 48 – 64 and have begun to experience the “aging process” firsthand
    • This generation has redefined each stage of their lives and is currently redefining aging
  • 15. BOOMERS REGARD AGING IS A DISEASE …
  • 16. … THAT AFFECTS EVERYONE
  • 17. … AND IS 100 PERCENT FATAL
  • 18. THIS IS THE NEW VIEW OF AGING Bob Delmonteque, age 84
  • 19. THE TWO PILLARS OF HEALTH Prevention Early Detection
  • 20. CANTERPENE CAN HELP AS A PREVENTIVE ANTIAGING STRATEGY
    • Science has linked numerous Cannabis compounds found in Canterpene with beneficial effects on the diseases resulting from “normal” aging
    • Canterpene captures much that other conventional hemp supplements have ignored
  • 21. Can Canterpene work as a lifespan enhancement tool?  
  • 22. THE MEDICAL BENEFITS
    • CANTERPENE
  • 23. NUMEROUS BIOCHEMICAL BENEFITS OF CANNABINOIDS IN HEMP
  • 24. SOME DISEASES/CONDITIONS ASSOCIATED WITH AGING
    • Oxidative stress
    • Arthritis
    • Central nervous system degeneration
    • Parkinson’s
    • Alzheimer’s
    Cannabidiol (CBD) the major cannabinoid in hemp has been shown to be of benefit in each of these and many other conditions
  • 25. OXIDATIVE STRESS
    • CBD treatment significantly reduced oxidative stress; decreased the levels of tumor necrosis factor, vascular endothelial growth factor, and intercellular adhesion molecule-1; and prevented retinal cell death and vascular hyperpermeability in the diabetic retina. Consistent with these effects, CBD treatment also significantly inhibited p38 MAP kinase in the diabetic retina. These results demonstrate that CBD treatment reduces neurotoxicity, inflammation, and BRB breakdown in diabetic animals.
    • EL Remessey AB et al. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol. 2006 Jan;168(1):235-44.
  • 26. ARTHRITIS
    • These potentially anti-inflammatory properties of CBD, together with the lack of psychotropic effect and low toxicity prompted us to test the potential of CBD as a therapeutic agent in collagen-induced arthritis (CIA).
    • RESULTS: “We report that CBD has a beneficial therapeutic action on established CIA.”
    • Malfait AM et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9561-6.
  • 27. PARKINSON’S DISEASE
    • Evidence suggests that cannabinoids may prove useful in Parkinson's disease by inhibiting the excitotoxic neurotransmitter glutamate and counteracting oxidative damage to dopaminergic neurons
    • Croxford JL. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs. 2003;17(3):179-202.
    • It seems that cannabinoids could delay or even stop progressive degeneration of brain dopaminergic systems, a process for which there is presently no prevention. In combination with currently used drugs, cannabinoids might represent, qualitatively, a new approach to the treatment of PD, making it more effective.
    • Sevcik J, Masek K Potential role of cannabinoids in Parkinson's disease DRUG AGING 16 (6): 391-395 JUN 2000
  • 28. ALZHEIMER’S DISEASE
    • Memory loss, the first and primary symptom of Alzheimer’s disease, can be slowed down significantly in mice by cannabidiol.
    • In a study at the Cajal Institute in Madrid, Spain, mice were injected with a molecule found in the brain of humans suffering from Alzheimer’s disease, and then treated for one week with cannabidiol.
    • Those mice injected with cannabidiol successfully performed the task within 25-30 seconds, compared to control mice, who took almost double the amount of time, 45-50 seconds, to complete the task.
    • See also: Iuvone T, Esposito G, Esposito R, et al. Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells J NEUROCHEM 89 (1): 134-141 APR 2004
  • 29. CANTERPENE AS AN ANTIAGING STRATEGY
    • GOOD SCIENCE WITHOUT A METHOD TO COMMERCIALIZE IT WILL NOT BENEFIT ANYONE
  • 30. Morris/Greg/Leah/Erin Rod Fisher Steve Burnside